News Archive

IDbyDNA Announces Agreement with ZeptoMetrix to Support Quality Control Products

IDbyDNA will use the Explify® metagenomics technology platform to provide ZeptoMetrix with identification, genotyping information, and genome sequences of reference strains and will assess the biological purity of these materials.

IDbyDNA and Rady Children’s Institute for Genomic Medicine Partner on Clinical Trial for the Identification of Pediatric Central Nervous System Infections

IDbyDNA’s Explify® platform will be used to analyze pathogens and immune reaction in cerebrospinal fluid of pediatric patients.

IDbyDNA Announces Strategic Partnership with the Fleury Group Medical and Health Organization to Utilize the Explify® Platform Across South America

IDbyDNA will license the Explify® platform for Fleury’s utilization in high quality clinical NGS-based metagenomic testing. Fleury labs provide healthcare analysis services across South America, with over 9,100 employees and 2,100 physicians.

IDbyDNA Announces New Scientific Advisory Board Members

IDbyDNA announced the appointment of two new members to its Scientific Advisory Board (SAB).

ARUP Magnify Winter 2018: Avoiding the Diagnostic Quandaries of Pneumonia — A New Test Uses New Technology

In the winter 2018 issue of their Magnify Magazine, our partner ARUP Laboratories discusses how they leveraged the Explify Platform to develop their Explify Respiratory test. Read more to learn how metagenomic testing is shifting the paradigm in the approach infectious disease diagnosis.

Locus Biosciences and IDbyDNA Partner to Develop Companion Diagnostic Test for Pseudomonas aeruginosa Infection

IDbyDNA and Locus Biosciences are partnering to develop companion precision diagnostics for patients with drug-resistant Pseudomonas aeruginosa infections who will benefit from Locus’ precision antimicrobials.

PM360 Names IDbyDNA One of The Healthcare Industry’s Most Innovative Startup Companies of 2017

PM360’s annual guide was established to provide a comprehensive overview of the latest advancements within healthcare and life sciences and offers brief profiles of each compelling innovation selected.

IDbyDNA and ARUP Laboratories Introduce Explify Respiratory: Breakthrough Technology to Diagnose Pneumonia Caused by Previously Undetected Pathogens

Metagenomics test identified pathogens missed by conventional lab tests in 44 percent of immunocompromised children treated for respiratory infection.

IDbyDNA and ARUP Laboratories Announce Partnership to Develop and Commercialize Novel Infectious Disease Testing Using Metagenomics

First test for pneumonia caused by previously undetected pathogen will be available through ARUP’s established national clinical network.

Genomeweb: Metagenomic Analysis Tool Taxonomer IDs Multiple Pathogens From Clinical Samples

Using the metagenomics analysis tool Taxonomer, researchers have been able to quickly tease out what pathogens are present in clinical and other samples.

Healio: Broad-Spectrum Testing Detects Pathogens in 34% of Patients with CAP of Unknown Cause

More effective pathogen identification will improve our understanding of pneumonia and guide treatment and site of care decisions.

CAP Today: With Metagenomic Sequencing, No Pathogen Can Hide

In contrast to most of our current tests, you can use a metagenomic approach to find any and all potential pathogens in a patient sample without having to know what you’re looking for,” says Robert Schlaberg.

Press Release: New England Journal of Medicine Publishes Study on Zika Genomic Sequence Identification by IDbyDNA

IDbyDNA, a precision medicine company focused on metagenomic approaches for infectious disease identification, today announced publication results in the New England Journal of Medicine that its metagenomics tool, Taxonomer, was used in the identification of Zika virus genomic sequence in the first Zika virus-related death in the continental U.S.

Press Release: IDbyDNA Raises $9 Million in Series A to Bring Precision Medicine to Infectious Diseases

IDbyDNA announced today that it has closed $9 million in Series A financing. ARTIS Ventures led the round, with additional investments from ARUP Laboratories and other private investors.

Diagnosis Ex Machina – A New Software Tool May Improve Upon Current Infectious Disease Diagnosis Methods to Return Faster, More Accurate Results

KSL.com: Feeling sick? Your Doctor Can Now Better Diagnose You Using Your DNA and the Internet

To determine the cause of certain diseases, scientists break open cells, extract the DNA and RNA and sequence them, a technique used for genome sequencing, now used in diagnostic labs.

Utah Public Radio: Scientists Unveil New Tool for Diagnosing Infectious Diseases

Pathogens like bacteria, fungi, viruses and parasites can give us illnesses ranging from a nagging cold to a life-threatening Staph infection. With its speed, accuracy, and user-friendliness, Taxonomer is pushing patient care, diagnostics, and basic science to new heights.

Nature Reviews Genetics: Pathogen Diagnostics for the Masses

Rapid identification of pathogens is vital for the accurate diagnosis and treatment of infectious diseases. A new bioinformatics tool that analyses and visualizes metagenomics data promises to speed up this process to a matter of minutes.

Genomeweb: IDbyDNA targeting clinical applications for University of Utah pathogen detection software

Scientists from the University of Utah, ARUP Laboratories, and bioinformatics startup IDbyDNA have developed Taxonomer, a metagenomics analysis platform for universal pathogen detection and host-response profiling.

Press Release: Ultra-fast, Meta-genomics Pathogen Detection Software for Diagnosing Infectious Diseases

In a paper published in Genome Biology, IDbyDNA and collaborators demonstrated the ability of Taxonomer to analyze the sequences of all nucleic acids in a clinical specimen (DNA and RNA) and to detect pathogens, as well as profile the patient’s gene expression, in a matter of minutes.